Theoret, Marc R.
United States Food and Drug Administration · Center for Drug Evaluation and Research
4 papers on CoChatORCID 0000-0003-4973-5297
Most cited papers
- Verified
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
Shrimali, R. K., Yu, Z., Theoret, M. R., Chinnasamy, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Cancer Research
Angiogenesis and VEGF in CancerCancer Immunotherapy and Biomarkers
Cited by 677
- Verified
Analysis of the association between adverse events and outcome in patients receiving a programmed death protein 1 or programmed death ligand 1 antibody
Maher, V. E., Fernandes, L. L., Weinstock, C., Tang, S., Agarwal, S., Brave, M., Ning, Y.-M., Singh, H., Suzman, D., Xu, J., et al. (2019) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments
Cited by 331
- Verified
Seamless Oncology-Drug Development
Prowell, T. M., Theoret, M. R., & Pazdur, R. (2016) · New England Journal of Medicine
Statistical Methods in Clinical TrialsPharmaceutical studies and practices
Cited by 126
- Verified
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs
Gao, W., Liu, J., Musante, C. J., Zhu, H., Thompson, M., Shah, M., Cao, Y., Ivaturi, V., Conaway, M. R., Bottino, D., et al. (2025) · Clinical Pharmacology & Therapeutics
Statistical Methods in Clinical TrialsPharmaceutical studies and practices
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free